Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$351.38 - $448.68 $1.83 Million - $2.34 Million
-5,209 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$372.64 - $458.3 $542,191 - $666,826
-1,455 Reduced 21.83%
5,209 $2.15 Million
Q2 2021

Aug 05, 2021

SELL
$294.17 - $371.65 $748,074 - $945,105
-2,543 Reduced 27.62%
6,664 $2.47 Million
Q1 2021

May 05, 2021

SELL
$249.67 - $299.48 $853,871 - $1.02 Million
-3,420 Reduced 27.08%
9,207 $2.67 Million
Q4 2020

Feb 04, 2021

SELL
$222.0 - $252.62 $9,546 - $10,862
-43 Reduced 0.34%
12,627 $3.16 Million
Q3 2020

Nov 02, 2020

SELL
$175.56 - $226.45 $11,235 - $14,492
-64 Reduced 0.5%
12,670 $2.87 Million
Q2 2020

Aug 05, 2020

BUY
$118.84 - $189.72 $54,191 - $86,512
456 Added 3.71%
12,734 $2.22 Million
Q1 2020

May 04, 2020

SELL
$98.9 - $178.34 $588,455 - $1.06 Million
-5,950 Reduced 32.64%
12,278 $1.55 Million
Q4 2019

Feb 07, 2020

SELL
$126.05 - $152.76 $13.6 Million - $16.5 Million
-108,274 Reduced 85.59%
18,228 $2.79 Million
Q3 2019

Nov 07, 2019

BUY
$125.07 - $143.67 $7.2 Million - $8.27 Million
57,561 Added 83.49%
126,502 $16.7 Million
Q2 2019

Jul 29, 2019

BUY
$123.4 - $148.55 $1.12 Million - $1.35 Million
9,099 Added 15.21%
68,941 $9.78 Million
Q1 2019

Apr 25, 2019

BUY
$104.82 - $146.73 $4.76 Million - $6.66 Million
45,390 Added 314.07%
59,842 $8.69 Million
Q4 2018

Feb 11, 2019

SELL
$105.09 - $137.23 $236,452 - $308,767
-2,250 Reduced 13.47%
14,452 $1.64 Million
Q3 2018

Nov 05, 2018

BUY
$112.11 - $134.54 $29,148 - $34,980
260 Added 1.58%
16,702 $2.25 Million
Q2 2018

Jul 31, 2018

BUY
$102.37 - $117.25 $10,237 - $11,725
100 Added 0.61%
16,442 $1.85 Million
Q1 2018

Apr 27, 2018

BUY
$98.19 - $115.2 $294,570 - $345,600
3,000 Added 22.49%
16,342 $1.74 Million
Q3 2017

Nov 06, 2017

BUY
$96.72 - $109.26 $16,539 - $18,683
171 Added 1.3%
13,342 $1.44 Million
Q2 2017

Aug 09, 2017

BUY
N/A
13,171
13,171 $1.33 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.